<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00922012</url>
  </required_header>
  <id_info>
    <org_study_id>2007-08-064</org_study_id>
    <nct_id>NCT00922012</nct_id>
  </id_info>
  <brief_title>Efficacy of Electromagnetic Stimulation Therapy for Chronic Prostatitis and Chronic Pelvic Pain Syndrome</brief_title>
  <official_title>Efficacy of Electromagnetic Stimulation Therapy for the Treatment of Chronic Prostatitis or Chronic Pelvic Pain Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>M-cube technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In 1995 the National Institutes of Health-National Institute of Diabetes and Digestive and&#xD;
      Kidney Diseases (NIDDK) workshop reached a consensus on the definition and classification of&#xD;
      prostatitis syndromes.The commonest and yet most poorly understood of these prostatitis&#xD;
      syndromes is category III or chronic pelvic pain syndrome (CPPS). It has been shown that,&#xD;
      while men with CPPS have significantly higher leukocyte counts in urine and expressed&#xD;
      prostatic secretions compared with age matched controls, inflammation and infection do not&#xD;
      necessarily correlate with symptom severity.&#xD;
&#xD;
      The lack of a direct relationship between inflammation and symptoms is supported through&#xD;
      studies of prostate histopathology, in which moderate or severe inflammation was identified&#xD;
      in only 5% of men with CPPS.Conventional treatment has focused on long, empirical courses of&#xD;
      expensive broad-spectrum antibiotics, mostly of the quinolone class, with or without the&#xD;
      concomitant use of an α-blocker and anti-inflammatory agents. At the turn of the 19th century&#xD;
      stimulation with electrical current and changing magnetic fields was used to treat surface&#xD;
      conditions associated with intractable pain, such as painful malignant ulcers. The analgesic&#xD;
      benefits of pulsed electromagnetic fields for relieving pelvic pain has been investigated in&#xD;
      women with tissue trauma and chronic refractory pelvic pain.Despite its uncertain etiology&#xD;
      there is some evidence that the symptom complex found in CPPS may be founded at least in part&#xD;
      in pelvic floor muscular dysfunction and/or neurogenic hypersensitivity/inflammation.&#xD;
&#xD;
      We hypothesized that the application of a electromagnetic stimulation to the perineum of the&#xD;
      subject may result in neural excitation and pelvic floor muscle stimulation to a degree that&#xD;
      breaks the cycle of tonic muscular spasm and neural hypersensitivity/inflammation, thereby,&#xD;
      restoring more normal pelvic floor muscular activity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in NIH-CPSI total and pain score</measure>
    <time_frame>24 weeks after treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in - NIH-CPSI urinary, QoL impact score - Qmax/PVR - frequency/24hrs - urgency episode/24hrs - Patient perception of treatment benefit, satisfaction, willingness to continue - Goal achievement - Patient's Perception of Symptom Improvement</measure>
    <time_frame>24 weeks of treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Chronic Prostatitis</condition>
  <condition>Chronic Pelvic Pain Syndrome</condition>
  <arm_group>
    <arm_group_label>Electromagnetic stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electromagnetic stimulation therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electromagnetic Stimulation Therapy</intervention_name>
    <description>Electromagnetic Stimulation Therapy for 24 weeks</description>
    <arm_group_label>Electromagnetic stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: male patients with&#xD;
&#xD;
          -  Age ≥ 18&#xD;
&#xD;
          -  NIDDK category III chronic prostatitis/chronic pelvic pain syndrome&#xD;
&#xD;
          -  Symptom duration ≥ 3 months&#xD;
&#xD;
          -  The sum of 1 or 2 domain of NIH-CPSI ≥ 1 point&#xD;
&#xD;
          -  The sum NIH-CPSI ≥ 15 points&#xD;
&#xD;
        Exclusion Criteria: patients with&#xD;
&#xD;
          -  History of prostate cancer&#xD;
&#xD;
          -  History of pelvic irradiation&#xD;
&#xD;
          -  History of transurethral surgery&#xD;
&#xD;
          -  Urinary tract infection within 6 months to screening&#xD;
&#xD;
          -  Postvoid urine volume ≥ 150ml&#xD;
&#xD;
          -  Interstitial cystitis&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyu-Sung Lee, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <study_first_submitted>June 16, 2009</study_first_submitted>
  <study_first_submitted_qc>June 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2009</study_first_posted>
  <last_update_submitted>May 10, 2011</last_update_submitted>
  <last_update_submitted_qc>May 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2011</last_update_posted>
  <responsible_party>
    <name_title>Kyu-Sung Lee/Professor</name_title>
    <organization>Samsung Medical Center</organization>
  </responsible_party>
  <keyword>Electromagnetic Stimulation Therapy</keyword>
  <keyword>Chronic Prostatitis</keyword>
  <keyword>Chronic Pelvic Pain Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatitis</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Pelvic Pain</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Somatoform Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

